Cargando…

Highly robust model of transcription regulator activity predicts breast cancer overall survival

BACKGROUND: While several multigene signatures are available for predicting breast cancer prognosis, particularly in early stage disease, effective molecular indicators are needed, especially for triple-negative carcinomas, to improve treatments and predict diagnostic outcomes. The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Chuanpeng, Liu, Jiannan, Chen, Steven X., Dong, Tianhan, Jiang, Guanglong, Wang, Yue, Wu, Huanmei, Reiter, Jill L., Liu, Yunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118819/ https://www.ncbi.nlm.nih.gov/pubmed/32241272 http://dx.doi.org/10.1186/s12920-020-0688-z

Ejemplares similares

Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice
por: Liu, Jiannan, et al.
Publicado: (2020)

Genetic Regulation of Human isomiR Biogenesis
por: Jiang, Guanglong, et al.
Publicado: (2023)

Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer
por: Dong, Chuanpeng, et al.
Publicado: (2022)

Nomograms-based prediction of overall and cancer-specific survivals for patients diagnosed with major salivary gland carcinoma
por: Guo, Zhiyong, et al.
Publicado: (2021)

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma
por: Dong, Chuanpeng, et al.
Publicado: (2021)

Bioinformatics detection of modulators controlling splicing factor‐dependent intron retention in the human brain
por: Chen, Steven X., et al.
Publicado: (2022)

Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
por: Diao, Jian‐dong, et al.
Publicado: (2019)

Differential Splicing of Skipped Exons Predicts Drug Response in Cancer Cell Lines
por: Simpson, Edward, et al.
Publicado: (2021)

A patient-oriented clinical decision support system for CRC risk assessment and preventative care
por: Liu, Jiannan, et al.
Publicado: (2018)

Inflammatory aging clock: A cancer clock to characterize the patients’ subtypes and predict the overall survival in glioblastoma
por: Zhu, Lei, et al.
Publicado: (2022)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

A nomogram for predicting the risk of male breast cancer for overall survival
por: Wen, Yahui, et al.
Publicado: (2023)

A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer
por: Zheng, Wei, et al.
Publicado: (2023)

The role of ferroptosis‐related genes for overall survival prediction in breast cancer
por: Jin, Li‐Yan, et al.
Publicado: (2021)

A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients
por: Chen, En-Guo, et al.
Publicado: (2017)

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer
por: Sun, Wei, et al.
Publicado: (2016)

A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

A nomogram to predict overall survival for biliary tract cancer
por: Song, Wei, et al.
Publicado: (2018)

Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma
por: Li, Tingting, et al.
Publicado: (2022)

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019)

A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma
por: Liang, Xin-Yi, et al.
Publicado: (2022)

COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1(+) neural-progenitor-like tumor cell in driving unfavorable outcome
por: Ji, Hang, et al.
Publicado: (2023)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

The prediction models for postoperative overall survival and disease‐free survival in patients with breast cancer
por: Shigemizu, Daichi, et al.
Publicado: (2017)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
por: Ma, Kexin, et al.
Publicado: (2019)

The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015)

Inflammatory breast cancer appearance at presentation is associated with overall survival
por: Balema, Wintana, et al.
Publicado: (2021)

Development and Validation of Nomograms for Predicting Overall and Breast Cancer–Specific Survival in Young Women with Breast Cancer: A Population-Based Study
por: Gong, Yue, et al.
Publicado: (2018)

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study
por: Liu, Xiaozhu, et al.
Publicado: (2021)

Identification of Pathway-Based Biomarkers with Crosstalk Analysis for Overall Survival Risk Prediction in Breast Cancer
por: Liu, Xiaohua, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

CLRM-07 A MULTIVARIATE RETROSPECTIVE ANALYSIS OF 159 PATIENTS WITH HIGH-GRADE GLIOMAS: OVERALL SURVIVAL, PROGRESSION-FREE SURVIVAL, AND PROGNOSTIC FACTORS
por: Liu, Shiyu, et al.
Publicado: (2022)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer Patients
por: Wang, Xiaolong, et al.
Publicado: (2021)

Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer
por: Zheng, Caihong, et al.
Publicado: (2023)

External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer
por: Jha, Ashish Kumar, et al.
Publicado: (2023)

High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma
por: Lu, Dong-Hui, et al.
Publicado: (2018)

Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer
por: Chen, Zonglin, et al.
Publicado: (2012)

A novel epigenetic signature for overall survival prediction in patients with breast cancer
por: Bao, Xuanwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9eabkf1o2u4mlnp72tn8sai96k